UB Paderborn / Katalog / Suche / in CDI

Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

Acta psychiatrica Scandinavica, 2019-05, Vol.139 (5), p.404-419

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study

Psychological medicine, 2017-07, Vol.47 (9), p.1668-1677

2017

Link zum Volltext

Verfügbarkeit prüfen

High suicide rates during psychiatric inpatient stay and shortly after discharge

Acta psychiatrica Scandinavica, 2020-11, Vol.142 (5), p.355-365

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk of homelessness after discharge from psychiatric wards in Denmark: a nationwide register‐based cohort study

Acta psychiatrica Scandinavica, 2019-11, Vol.140 (5), p.477-489

2019

Link zum Volltext

Verfügbarkeit prüfen

Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis

Acta psychiatrica Scandinavica, 2020-03, Vol.141 (3), p.231-240

2020

Link zum Volltext

Verfügbarkeit prüfen

The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial

Trials, 2022-09, Vol.23 (1), p.773-773, Article 773

2022

Link zum Volltext

Verfügbarkeit prüfen

Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis

Acta psychiatrica Scandinavica, 2017-03, Vol.135 (3), p.250-258

2017

Link zum Volltext

Verfügbarkeit prüfen

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

European psychiatry, 2020-08, Vol.63 (1), p.e83-e83, Article e83

2020

Link zum Volltext

Verfügbarkeit prüfen

Stability and development of psychotic symptoms and the use of antipsychotic medication – long-term follow-up

Psychological medicine, 2017-09, Vol.47 (12), p.2118-2129

2017

Link zum Volltext

Verfügbarkeit prüfen

Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial

Psychological medicine, 2014-01, Vol.44 (1), p.117-126

2014

Link zum Volltext

Verfügbarkeit prüfen

Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

Psychological medicine, 2013-07, Vol.43 (7), p.1499-1510

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of the Irritable Bowel Syndrome — A longitudinal follow-up study of the general population in Denmark

Journal of psychosomatic research, 2015-06, Vol.78 (6), p.619-620

2015

Link zum Volltext

Verfügbarkeit prüfen

High loading of polygenic risk in cases with chronic schizophrenia

Molecular psychiatry, 2016-07, Vol.21 (7), p.969-974

2016

Link zum Volltext

Verfügbarkeit prüfen

P03-179 CapOpus trial: An observer-blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis abuse and psychosis

European psychiatry, 2009, Vol.24, p.S1178-S1178

2009

Link zum Volltext

Verfügbarkeit prüfen

P.389 Baseline cortisol, psychotic symptoms and clinical outcome after one year in ultra high-risk patients

European neuropsychopharmacology, 2019-12, Vol.29, p.S275-S276

2019

Link zum Volltext

Verfügbarkeit prüfen

Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis

Schizophrenia bulletin, 2015-05, Vol.41 (3), p.617-626

2015

Link zum Volltext

Verfügbarkeit prüfen

Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care - a long-term, population-based study

Clinical epidemiology, 2017-01, Vol.9, p.393-402

2017

Link zum Volltext

Verfügbarkeit prüfen

Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016

Psychological medicine, 2023-08, Vol.53 (11), p.5246-5255

2023

Link zum Volltext

Verfügbarkeit prüfen

CAPOPUS Trial: an Observer-blinded RCT of Specialized Addiction Treatment Versus Standard Treatment for Young Patients with Cannabis Abuse and Psychosis

European psychiatry, 2009-01, Vol.24 (S1), Article 24-E1178

2009

Link zum Volltext

Verfügbarkeit prüfen

Suicide and unintentional injury mortality among homeless people: a Danish nationwide register-based cohort study

European journal of public health, 2014-02, Vol.24 (1), p.50-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Assertive interventions for first episode psychoses: The Danish experience

European psychiatry, 2017-04, Vol.41 (S1), p.S4-S4

2017

Link zum Volltext

Verfügbarkeit prüfen

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis-A Randomized Clinical Trial

Frontiers in psychiatry, 2020-08, Vol.11, p.873-873

2020

Link zum Volltext

Verfügbarkeit prüfen

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL

Schizophrenia bulletin, 2020-05, Vol.46 (Supplement_1), p.S237-S238

2020

Link zum Volltext

Verfügbarkeit prüfen

INTERIM ANALYSIS OF THE CAPOPUS TRIAL: A RANDOMIZED, PARALLEL-GROUP, OBSERVER-BLINDED CLINICAL TRIAL OF SPECIALIZED ADDICTION TREATMENT VERSUS TREATMENT AS USUAL FOR YOUNG PATIENTS WITH CANNABIS ABUSE AND PSYCHOSIS

Schizophrenia research, 2010-04, Vol.117 (2), p.190-190

2010

Link zum Volltext

Verfügbarkeit prüfen

Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

Trials, 2008-07, Vol.9 (1), p.42-42, Article 42

2008

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials

Association between alcohol, cannabis, and other illicit substance abuse and risk of developing schizophrenia: a nationwide population based register study

High suicide rates during psychiatric inpatient stay and shortly after discharge

Risk of homelessness after discharge from psychiatric wards in Denmark: a nationwide register‐based cohort study

Basic symptoms influence real‐life functioning and symptoms in individuals at high risk for psychosis

The CHALLENGE trial: the effects of a virtual reality-assisted exposure therapy for persistent auditory hallucinations versus supportive counselling in people with psychosis: study protocol for a randomised clinical trial

Negative symptoms mediate the relationship between neurocognition and function in individuals at ultrahigh risk for psychosis

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months

Stability and development of psychotic symptoms and the use of antipsychotic medication – long-term follow-up

Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial

Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial

Prognosis of the Irritable Bowel Syndrome — A longitudinal follow-up study of the general population in Denmark

High loading of polygenic risk in cases with chronic schizophrenia

P03-179 CapOpus trial: An observer-blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis abuse and psychosis

P.389 Baseline cortisol, psychotic symptoms and clinical outcome after one year in ultra high-risk patients

Ten-year follow-up of the OPUS specialized early intervention trial for patients with a first episode of psychosis

Irritable bowel symptoms and the development of common mental disorders and functional somatic syndromes identified in secondary care - a long-term, population-based study

Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016

CAPOPUS Trial: an Observer-blinded RCT of Specialized Addiction Treatment Versus Standard Treatment for Young Patients with Cannabis Abuse and Psychosis

Suicide and unintentional injury mortality among homeless people: a Danish nationwide register-based cohort study

Assertive interventions for first episode psychoses: The Danish experience

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis-A Randomized Clinical Trial

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL

INTERIM ANALYSIS OF THE CAPOPUS TRIAL: A RANDOMIZED, PARALLEL-GROUP, OBSERVER-BLINDED CLINICAL TRIAL OF SPECIALIZED ADDICTION TREATMENT VERSUS TREATMENT AS USUAL FOR YOUNG PATIENTS WITH CANNABIS ABUSE AND PSYCHOSIS

Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis

Suchergebnisse filtern